Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Leiomyoma × relugolix × Clear all

Status

Sponsor Class

INDUSTRY 8 OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 21 Prostate Adenocarcinoma 2 Adenocarcinoma 2 Uterine Neoplasms 1 Uterine Hemorrhage 1 Pathologic Complete Response 1 Neoplasm, Residual 1 Myoma 1 Myofibroma 1 Metastatic Hormone-sensitive Prostate Cancer (mHSPC) 1 Leiomyoma 1

Interventions

ulipristal acetate 11 Uterine Myomectomy 8 Uterine Artery Embolization 7 Tranexamic Acid 6 Bupivacaine 6 Mifepristone 5 Leuprolide 5 Saline Solution 4 Letrozole 4 Hysterectomy 4 epigallocatechin gallate 3 Sodium Chloride 3 Misoprostol 3 Gonadotropin-Releasing Hormone 3 Embolization, Therapeutic 3 ulipristal 2 cetrorelix 2 Vitamin B 6 2 Tea 2 Tablets 2 Surveys and Questionnaires 2 Radiofrequency Ablation 2 Observation 2 Lidocaine 2 Hysteroscopy 2 Goserelin 2 Gonadotropins 2 Chorionic Gonadotropin 2 Anesthesia, General 2 tibolone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06953076 2025-08-17

MySaturn

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Leiomyoma, Myoma, Uterine Hemorrhage, Uterine Neoplasms, Myofibroma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡